Bavarian Nordic receives USD 25 million milestone payment after submission of IMVAMUNE data to the U.S. Health Authorities

21-Nov-2008 - USA

Bavarian Nordic has invoiced the U.S. authorities for another milestone payment of USD 25 million as allowed under the RFP-3 contract to manufacture and deliver 20 million doses of the company's IMVAMUNE® smallpox vaccine. This milestone payment was triggered by the recent submission of a clinical safety report from a large Phase II study with IMVAMUNE® in HIV infected subjects, which is part of the regulatory package that will be used to potentially support the use of IMVAMUNE® in a declared emergency. With this, Bavarian Nordic is an important step closer to fulfilling the conditions for initiating delivery of IMVAMUNE® in 2009.

With this payment, Bavarian Nordic has so far invoiced a total of USD 125 million in advance- and milestone payments under the RFP-3 contract, of which USD 50 million has not yet been recognised in the income statement.

Anders Hedegaard, President & CEO of Bavarian Nordic, said: "Since the award of the RFP-3 we have successfully met all agreed objectives in the contract with the U.S. Department of Health and Human Services and we find this very satisfactory. The submission of these clinical data concludes the data package that may support the use of IMVAMUNE® in a declared emergency and marks an important event for the company this year. This submission is part of the company's plan to support the delivery of IMVAMUNE® which is planned to start during 2009".

Other news from the department research and development

Most read news

More news from our other portals

Is artificial intelligence revolutionizing the life sciences?

Last viewed contents

Cellular contamination pathway for plutonium, other heavy elements, identified - Scientists find that an iron-binding protein can transport actinides into cells

Cellular contamination pathway for plutonium, other heavy elements, identified - Scientists find that an iron-binding protein can transport actinides into cells

Salmon genome in final phases of completion

Lundbeck expands the agreement with Teva to include marketing of Azilect in selected Asian countries

Novartis data shows ACZ885 for severe gouty arthritis provided better pain relief and reduced risk of new attacks by up to 68% vs. steroid - Two pivotal Phase III studies showed ACZ885 may meet significant unmet need for patients for whom many standard therapies are inadequate or inappropriate

Breakthrough in mapping nicotine addiction could help researchers improve treatment

Breakthrough in mapping nicotine addiction could help researchers improve treatment

Study shows how bioactive substance inhibits important receptor - Results from the University of Bonn raise hope for new drugs against cancer and brain diseases

Study shows how bioactive substance inhibits important receptor - Results from the University of Bonn raise hope for new drugs against cancer and brain diseases

Natural UV radiation in winter not strong enough against SARS-CoV-2 - In winter the virus has a good chance of survival outside

Natural UV radiation in winter not strong enough against SARS-CoV-2 - In winter the virus has a good chance of survival outside

Covestro and Genomatica produce important chemical raw material using biotechnology - Breakthrough for HMDA, widely-used ingredient, paves the way for more sustainable coatings, apparel, adhesives and plastics

Covestro and Genomatica produce important chemical raw material using biotechnology - Breakthrough for HMDA, widely-used ingredient, paves the way for more sustainable coatings, apparel, adhesives and plastics

How the body’s defenses keep their weapons in check - Protection against deadly infection

How the body’s defenses keep their weapons in check - Protection against deadly infection

Pulmo BioTech Inc. completes bio-distribution studies

Laryngomalacia

What determines whether we become overweight? - More than just lifestyle and genes: New factor influencing excess body weight discovered

What determines whether we become overweight? - More than just lifestyle and genes: New factor influencing excess body weight discovered